Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Henderson Global Investors
AddedFeb 13, 2024
UpdatedJul 16, 2026
Henderson Global Investors

Henderson Global Investors

Acquired

Janus Henderson: A British-American global investment manager offering diverse financial products worldwide.

Location
London, Greater London, GB
Founded
1934
Firm
Compare
Portfolio
Fundraising
Employees
Website

Janus Henderson Investors is a British-American global asset management group headquartered in London, offering a diverse range of financial products to individual, intermediary, and institutional investors worldwide. The firm typically invests in Series A, B, C, and later-stage rounds, with a focus on sectors such as biotechnology, therapeutics, and technology. Their investment sizes vary significantly, often ranging from early-stage investments to substantial post-IPO equity.

Notable portfolio companies include 2seventy bio, 4D Molecular Therapeutics, and Freenome. Key partners at Janus Henderson bring extensive experience from leading financial institutions. The firm's investment philosophy emphasizes long-term growth and innovation. Additionally, Janus Henderson offers unique value-add services such as strategic guidance and access to a global network of industry experts, enhancing the growth potential of their portfolio companies.

Henderson Global Investors - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments64
Current Portfolio Count53
Total Portfolio Exits2

Top Investment Stages

Series B26 (44.8%)
Post Ipo Equity11 (19.0%)
Series C11 (19.0%)
Series A8 (13.8%)
Series D2 (3.4%)

Stage Mix

Series B 45%Post Ipo Equity 19%Series C 19%Series A 14%Series D 3%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Claris Biotherapeutics logo

Claris Biotherapeutics

Parse Biosciences logo

Parse Biosciences

Bicara Therapeutics logo

Bicara Therapeutics

Benitec Biopharma logo

Benitec Biopharma

Immunome logo

Immunome

Carmot Therapeutics logo

Carmot Therapeutics

Heartflow logo

Heartflow

Chroma Medicine logo

Chroma Medicine

Via logo

Via

Entact Bio logo

Entact Bio

Curevo logo

Curevo

Elektrofi logo

Elektrofi

IntelyCare logo

IntelyCare

2seventy bio logo

2seventy bio

Magnolia Medical Technologies logo

Magnolia Medical Technologies

Inspirato logo

Inspirato

Ceptur Therapeutics logo

Ceptur Therapeutics

Freenome logo

Freenome

P3 Health Partners logo

P3 Health Partners

Arbor Biotechnologies logo

Arbor Biotechnologies

Shoreline Biosciences logo

Shoreline Biosciences

Cedilla Therapeutics logo

Cedilla Therapeutics

Attralus logo

Attralus

Asher Bio logo

Asher Bio

Tango Therapeutics logo

Tango Therapeutics

Henderson Global Investors - Similar Investment Firms

Janus Fund logo

Janus Fund

janushenderson.com

John Hancock Investments logo

John Hancock Investments

Jensen Investment Management logo

Jensen Investment Management

Federated Hermes logo

Federated Hermes

J.P. Morgan Asset Management logo

J.P. Morgan Asset Management

U.S. Global Investors logo

U.S. Global Investors

usfunds.com

Schroders logo

Schroders

schroders.com

JAM Equity Partners logo

JAM Equity Partners

jampartners.com

Summit Partners logo

Summit Partners

summitpartners.com

Viking Global Investors logo

Viking Global Investors

vikingglobal.com

Point72 Asset Management logo

Point72 Asset Management

point72.com

Jennison Associates logo

Jennison Associates

jennison.com

Marshall Wace logo

Marshall Wace

mwam.com

Turner Investments logo

Turner Investments

Wellington Management logo

Wellington Management

wellington.com

Henderson Global Investors - Classification

Also Known As
  • Henderson Global Investors Limited
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
ISIC
  • 6499Other financial service activities, except insurance and pension funding activities, n.e.c.
Show 5 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified